Abstract
Purpose
This study aimed to validate the disease-specific “quality of life in short stature youth (QoLISSY)-instrument” that assessesQuery the health-related quality of life (HrQoL) in German children and adolescents diagnosed as small for gestational age (SGA) in a patient and parent report.
Methods
The psychometric performance of the German version of the QoLISSY questionnaire was examined in terms of reliability and validity in 65 SGA families (17 child reports/64 parent reports) and compared to the psychometric performance of the original European QoLISSY dataset of over 200 children with growth hormone deficiency and idiopathic short stature (ISS).
Results
The analysis yielded psychometrically favorable results with excellent reliability and acceptable discriminant validity. The instrument’s operating characteristics were comparable to the results of the original European QoLISSY data. In the parent- as well as child report, children with SGA had lower HrQoL scores than children with ISS. Convergent validity was demonstrated by significant correlations between the QoLISSY scales and the generic KIDSCREEN-10 Index.
Conclusion
Psychometric testing suggests that QoLISSY is a promising instrument to assess the HrQoL of young German people with SGA. Both versions (parent- and child report) appear to detect differences between SGA and other conditions (e.g. ISS). QoLISSY can be used in clinical studies, health service research, as well as in practice in children with SGA and their parents. For a cross-cultural application of the instrument in SGA, the tool needs be validated in sufficiently large SGA samples within respective countries.
Similar content being viewed by others
References
Wit JM, Reiter EO, Ross JL, Saenger PH, Savage MO, Rogol AD, Cohen P (2008) Idiopathic short stature: management and growth hormone treatment. Growth Hormon IGF Res 18(2):111–135
Lee PA, Chernausek SD, Hokken-Koelega AC, Czernichow P (2003) International small for gestational age advisory board consensus development conference statement: management of short children born small for gestational age, April 24-October 1, 2001. Pediatrics 111(6 Pt 1):1253–1261
Sandberg D, Gardner M (2015) Short stature: is it a psychosocial problem and does changing height matter? Pediatr Clin N Am 62:963–982. https://doi.org/10.1016/j.pcl.2015.04.009
Haymond M, Kappelgaard AM, Czernichow P, Biller BM, Takano K, Kiess W (2013) Early recognition of growth abnormalities permitting early intervention. Acta Paediatr 102(8):787–796. https://doi.org/10.1111/apa.12266
Hoepffner W, Pfaffle R, Gausche R, Meigen C, Keller E (2011) Early detection of growth disorders with the CrescNet system at the Leipzig treatment center. Dtsch Arztebl Int 108(8):123–128. https://doi.org/10.3238/arztebl.2011.0123
Ergun-Longmire B, Wajnrajch M (2000) Growth and growth disorders. In: De Groot LJ, Chrousos G, Dungan K et al (eds) Endotext. MDText.com Inc, South Dartmouth
Voigt M, Rochow N, Schneider KTM, Hagenah HP, Scholz R, Hesse V, Wittwer-Backofen U, Straube S, Olbertz D (2014) Neue Perzentilwerte für die Körpermaße neugeborener Einlinge: ergebnisse der deutschen Perinatalerhebung der Jahre 2007–2011 unter Beteiligung aller 16 Bundesländer (New percentile values for the anthropometric dimensions of singleton neonates: analysis of perinatal survey data of 2007–2011 from all 16 States of Germany). Z Geburtshilfe Neonatol 218(05):210–217. https://doi.org/10.1055/s-0034-1385857
Saenger P, Czernichow P, Hughes I, Reiter EO (2007) Small for gestational age: short stature and beyond. Endocr Rev 28(2):219–251. https://doi.org/10.1210/er.2006-0039
Sandberg DE, Gardner M (2015) Short stature: is it a psychosocial problem and does changing height matter? Pediatr Clin N Am. https://doi.org/10.1016/j.pcl.2015.04.009
Geisler A, Lass N, Reinsch N, Uysal Y, Singer V, Ravens-Sieberer U, Reinehr T (2012) Quality of life in children and adolescents with growth hormone deficiency: association with growth hormone treatment. Horm Res Paediatr 78(2):94–99. https://doi.org/10.1159/000341151
Voss LD, Mulligan J (2000) Bullying in school: are short pupils at risk? Questionnaire study in a cohort. BMJ 320(7235):612–613
Bannink EM, van Pareren YK, Theunissen NC, Raat H, Mulder PG, Hokken-Koelega AC (2005) Quality of life in adolescents born small for gestational age: does growth hormone make a difference? Horm Res 64(4):166–174. https://doi.org/10.1159/000088792
The European QoLISSY Group (2013) Quality of life in short stature youth. The QoLISSY questionnaire—user’s manual. Pabst Science Publishers, Lengerich
Rohenkohl A, De Schepper J, Vanderfaeillie J, Fricke K, Hendrickx S, Lagrou K, Bullinger M, Quitmann J, Group tQS (2014) Validation of the Flemish version of the quality of life in short stature youth (QoLISSY) questionnaire. Acta Clin Belg 69(3):177–182
Rohenkohl A, Stalman S, Kamp G, Bullinger M, Quitmann J (2015) Psychometric performance of the quality of life in short stature youth (QoLISSY) questionnaire in the Netherlands. Eur J Pediatr. https://doi.org/10.1007/s00431-015-2656-8
Quitmann J, Giammarco A, Maghnie M, Napoli F, Di Giovanni I, Carducci C, Mohn A, Bullinger M, Sommer R (2017) Validation of the Italian quality of life in short stature youth (QoLISSY) questionnaire. J Endocrinol Investig. https://doi.org/10.1007/s40618-017-0667-1
Bullinger M, Sommer R, Pleil A, Mauras N, Ross J, Newfield R, Silverman L, Rohenkohl A, Fox J, Quitmann J (2015) Evaluation of the American-English Quality of Life in Short Stature Youth (QoLISSY) Questionnaire in the United States. Health Qual Life Outcomes. https://doi.org/10.1186/s12955-015-0236
Rohenkohl AC, Bullinger M, Quitmann J (2015) Quality of life in children, adolescents, and young adults with achondroplasia. Orthopade 44(3):212–218
Menzel U (2014) Gesundheitsbezogene Lebensqualität bei kleinwüchsigen Kindern und Jugendlichen. Monograph. University Hamburg, Hamburg
Weber J, Lamb D (1970) Statistics and research in physical education. CV Mosby Co, St. Louis
Bortz J, Döring N (2006) Forschungsmethoden und evaluation für Humanwissenschaftler. Springer, Heidelberg
Kromeyer-Hausschild K, Wabitsch M, Kunze D, Geller F, Geiß H, Hesse V (2001) Perzentile für den Body-mass-Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutsche Stichproben. Monatsschr Kinderheilkd 147(8):807–820
SPSS Inc. (2009) PASW for windows, Version 18.0. SPSS Inc., Chicago
Clayton P, Bonnemaire M, Dutailly P, Maisonobe P, Naudin L, Pham E, Zhang Z, Grupe A, Thiagalingam A, Denefle P, Group ES (2013) Characterizing short stature by insulin-like growth factor axis status and genetic associations: results from the prospective, cross-sectional, epidemiogenetic EPIGROW study. J Clin Endocrinol Metab 98(6):E1122–E1130. https://doi.org/10.1210/jc.2012-4283
Rohenkohl A, Sommer R, Bestges S, Kahrs S, Klingebiel KH, Bullinger M, Quitmann J (2015) Leben mit Achondroplasie: wie beurteilen junge Menschen mit disproportioniertem Kleinwuchs ihre Lebensqualität und mit welchen Faktoren ist sie assoziiert? Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie 43(6):433–441. https://doi.org/10.1024/1422-4917/a000385
Silva N, Bullinger M, Quitmann J, Ravens-Sieberer U, Rohenkohl A (2013) HRQoL of European children and adolescents with short stature as assessed with generic (KIDSCREEN) and chronic-generic (DISABKIDS) instruments. Expert Rev Pharmacoecon Outcomes Res 13(6):817–827. https://doi.org/10.1586/14737167.2013.847366
Bullinger M, Koltowska-Haggstrom M, Sandberg D, Chaplin J, Wollmann H, Noeker M, Brutt AL (2009) Health-related quality of life of children and adolescents with growth hormone deficiency or idiopathic short stature—part 2: available results and future directions. Horm Res 72(2):74–81. https://doi.org/10.1159/000232159
Aabenhus R, Thorsen H, Siersma V, Brodersen J (2013) The development and validation of a multidimensional sum-scaling questionnaire to measure patient-reported outcomes in acute respiratory tract infections in primary care: the acute respiratory tract infection questionnaire. Value Health 16(6):987–992. https://doi.org/10.1016/j.jval.2013.06.011
Acknowledgements
The QoLISSY prospective project would like to thank the children, parents, and staff from the participating clinical centers, particularly Prof. Dr. Dörr and Dr. Menzel for their participation and contributions. Funding was provided by Pfizer UK.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Access to the QoLISSY instrument
QoLISSY is a joint initiative between Pfizer Limited and the University Medical Center Hamburg-Eppendorf. Copyright Pfizer Limited all rights reserved. The European QoLISSY instrument, together with comprehensive information of its development and validation process is published in the QoLISSY’s User’s Manual (Pabst Science Publishers, Lengerich, 2013). The Manual, which is available upon request, includes QoLISSY child and parent forms, as well as scoring information (http://www.pfizerpatientreportedoutcomes.com/therapeutic-areas/cv-metabolic/endocrine).
Conflict of interest
This study was sponsored by Pfizer, Inc. RS, JB, MB, and JQ received research funding for the conduct of the study. The authors received no financial support for the development of the manuscript.
Ethical standards
The study has been approved by the appropriate ethics committee and has, therefore, been performed in accordance with the ethical standard laid down in the 1964 Declaration of Helsinki and its later amendments.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Sommer, R., Blömeke, J., Bullinger, M. et al. The psychometric evaluation of the quality of life in short stature youth (QoLISSY) instrument for German children born small for gestational age. J Endocrinol Invest 41, 1185–1191 (2018). https://doi.org/10.1007/s40618-018-0850-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-018-0850-z